Scroll to top
Tag: blended treatment

FDA Clears Prescription Digital Behavioral Therapeutic for Type 2 Diabetes

Article Excerpt: The Food and Drug Administration (FDA) has cleared AspyreRx™, a prescription digital behavioral therapeutic device for adults with type 2 diabetes.The device is intended to provide cognitive behavioral therapy (CBT), as an adjunct to standard of care, to patients aged 18 years and older with type 2 diabetes under the care of a health care provider. Prescribed in 90-day increments, the digital therapeutic delivers CBT through a mobile application in a weekly, step-by-step process to help patients improve glycemic control.

Full Article:

Article Source: Psychiatry Advisor


Groups Doubles Down on Telehealth with A Mobile App to Treat Opioid Addiction

Article Excerpt: Like many healthcare provider organizations, Groups, a value-based care provider of opioid-addiction treatment, had to respond to the COVID-19 pandemic overnight. To keep members safe, the organization made the decision to close all 120 of its clinics across the country and transition to 100% virtual opioid-use-disorder treatment services. To accomplish this, Groups provided its members with a number of different digital health technologies that enabled them to continue their treatment virtually and do all of the form submissions, drug screens and insurance processes that are part of the Groups recovery program.

Full Article:

Article Source: Healthcare IT News


Implementing a Pharmacist-Integrated Collaborative Model of Medication Treatment for Opioid Use Disorder (PharmICO) –

Article Excerpt: Study about a treatment model for opioid use disorder with Lisa A. Marsch, Director of the Center for Technology and Behavioral Health as the principal investigator.

Full Article:

Article Source: Dartmouth Geisel School of Medicine News


Wearable Sensor May Help Curb Opioid Relapses, Overdoses

Article Excerpt: Researchers from the University of Massachusetts Amherst, Syracuse University and SUNY Upstate Medical University have collaborated to create a wireless senor designed to prevent opioid relapses and overdoses. The opioid epidemic has steadily worsened across the country since the late 1990s. In 2019, nearly 50,000 people in the U.S. died from opioid-related overdoses, according to data from the National Institute on Drug Abuse. Further, around 21 to 29 percent of patients prescribed opioids for chronic pain misuse them, the federal data shows.To combat this issue, the research team — headed by Tauhidur Rahman, PhD, an assistant professor in the College of Information and Computer Sciences at UMass Amherst and co-director of the MOSAIC Lab — is developing a sensor, which will use machine learning to pinpoint psychophysiological signs in real time and determine whether they are consistent with opioid cravings. Cravings are one of the main drivers behind relapses and overdoses.

Full Article:

Article Source: mHealth Intelligence


Blended smoking cessation treatment: Exploring measurement, levels, and predictors of adherence

Siemer L, Brusse-Keizer MGJ, Postel MG, et al. (2018). Blended smoking cessation treatment: Exploring measurement, levels, and predictors of adherence. Journal of Medical Internet Research. 20(8): e246. doi: 10.2196/jmir.9969

Researchers explored adherence to smoking cessation treatment among participants in a randomized controlled study (n=75) that received 5 sessions each of web-based and face-to-face treatment. Read More